MAPK7 anticorps (C-Term, Isoform 2)
Aperçu rapide pour MAPK7 anticorps (C-Term, Isoform 2) (ABIN4889327)
Antigène
Voir toutes MAPK7 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term, Isoform 2
-
Specificité
- Reacts with the human MAPK7 isoform 2
-
Purification
- Purified (protein A)
-
Immunogène
- synthetic peptide derived from C terminal part of human MAPK7 isoform 2
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only : -
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Must be reconstituted in distilled water.
-
Buffer
- Tris 0.1 M, glycine 0.1 M, sucrose 2 %
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Date de péremption
- 24 months
-
-
- MAPK7 (Mitogen-Activated Protein Kinase 7 (MAPK7))
-
Autre désignation
- MAPK7
-
Sujet
- Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.
-
Pathways
- Signalisation MAPK, Neurotrophin Signaling Pathway, Activation of Innate immune Response, cAMP Metabolic Process, Toll-Like Receptors Cascades, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-